| Antagonist activity at FPR1 in whole blood assessed as CD11 level - BioAssay Summary A series of pyrazole inhibitors of the human FPR1 receptor have been identified from high throughput screening. The compounds demonstrate potent inhibition in human neutrophils and attractive physicochemical and in vitro DMPK profiles to be of further interest. ..more |
_ | |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
BioActive Compounds: 2 Description: Title: Discovery of pyrazoles as novel FPR1 antagonists. Abstract: A series of pyrazole inhibitors of the human FPR1 receptor have been identified from high throughput screening. The compounds demonstrate potent inhibition in human neutrophils and attractive physicochemical and in vitro DMPK profiles to be of further interest. (PMID: 21955939) Comment Compounds with activity <= 50uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation. Putative Target: ChEMBL Target ID: 13010 Target Type: SINGLE PROTEIN Pref Name: Formyl peptide receptor 1 Description: fMet-Leu-Phe receptor Organism: Homo sapiens Tax ID: 9606 Confidence: Homologous single protein target assigned Relationship Type: Homologous protein target assigned ChEMBL target type: Target is a single protein chain Categorized Comment ChEMBL Assay Type: Functional ChEMBL Assay Data Source: Scientific Literature Result Definitions
* Activity Concentration. Data Table (Concise)
PageFrom: |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||